Insider Transactions in Q3 2023 at Anixa Biosciences Inc (ANIX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 31
2023
|
Amit Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,800
-2.49%
|
$35,400
$3.57 P/Share
|
|
Jul 28
2023
|
Amit Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,375
-5.65%
|
$85,125
$3.63 P/Share
|
|
Jul 28
2023
|
Amit Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+7.38%
|
$80,000
$2.58 P/Share
|
|
Jul 27
2023
|
Lewis H Titterton Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
87,042
-9.74%
|
$261,126
$3.55 P/Share
|
|
Jul 27
2023
|
Lewis H Titterton Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
120,000
+11.83%
|
$240,000
$2.58 P/Share
|
|
Jul 20
2023
|
Michael Catelani President, COO, & CFO |
BUY
Open market or private purchase
|
Direct |
5,500
+17.1%
|
$16,500
$3.64 P/Share
|